Exploring Possible Drug-Resistant Variants of SARS-CoV‑2 Main Protease (Mpro) with Noncovalent Preclinical Candidate, Mpro61

Saved in:
Bibliographic Details
Main Authors: Jessica R. Kenneson, Christina Papini, Su Tang, Kathy Huynh, Chun-Hui Zhang, William L. Jorgensen, Karen S. Anderson
Format: Article
Language:English
Published: American Chemical Society 2025-01-01
Series:ACS Bio & Med Chem Au
Online Access:https://doi.org/10.1021/acsbiomedchemau.4c00109
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849716512703643648
author Jessica R. Kenneson
Christina Papini
Su Tang
Kathy Huynh
Chun-Hui Zhang
William L. Jorgensen
Karen S. Anderson
author_facet Jessica R. Kenneson
Christina Papini
Su Tang
Kathy Huynh
Chun-Hui Zhang
William L. Jorgensen
Karen S. Anderson
author_sort Jessica R. Kenneson
collection DOAJ
format Article
id doaj-art-e154cd632ddc435d95d3f4f2ab1d7fbb
institution DOAJ
issn 2694-2437
language English
publishDate 2025-01-01
publisher American Chemical Society
record_format Article
series ACS Bio & Med Chem Au
spelling doaj-art-e154cd632ddc435d95d3f4f2ab1d7fbb2025-08-20T03:12:58ZengAmerican Chemical SocietyACS Bio & Med Chem Au2694-24372025-01-015121522610.1021/acsbiomedchemau.4c00109Exploring Possible Drug-Resistant Variants of SARS-CoV‑2 Main Protease (Mpro) with Noncovalent Preclinical Candidate, Mpro61Jessica R. Kenneson0Christina Papini1Su Tang2Kathy Huynh3Chun-Hui Zhang4William L. Jorgensen5Karen S. Anderson6Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut, United StatesDepartment of Pharmacology, Yale University School of Medicine, New Haven, Connecticut, United StatesDepartment of Pharmacology, Yale University School of Medicine, New Haven, Connecticut, United StatesDepartment of Pharmacology, Yale University School of Medicine, New Haven, Connecticut, United StatesDepartment of Chemistry, Yale University, New Haven, Connecticut, United StatesDepartment of Chemistry, Yale University, New Haven, Connecticut, United StatesDepartment of Pharmacology, Yale University School of Medicine, New Haven, Connecticut, United Stateshttps://doi.org/10.1021/acsbiomedchemau.4c00109
spellingShingle Jessica R. Kenneson
Christina Papini
Su Tang
Kathy Huynh
Chun-Hui Zhang
William L. Jorgensen
Karen S. Anderson
Exploring Possible Drug-Resistant Variants of SARS-CoV‑2 Main Protease (Mpro) with Noncovalent Preclinical Candidate, Mpro61
ACS Bio & Med Chem Au
title Exploring Possible Drug-Resistant Variants of SARS-CoV‑2 Main Protease (Mpro) with Noncovalent Preclinical Candidate, Mpro61
title_full Exploring Possible Drug-Resistant Variants of SARS-CoV‑2 Main Protease (Mpro) with Noncovalent Preclinical Candidate, Mpro61
title_fullStr Exploring Possible Drug-Resistant Variants of SARS-CoV‑2 Main Protease (Mpro) with Noncovalent Preclinical Candidate, Mpro61
title_full_unstemmed Exploring Possible Drug-Resistant Variants of SARS-CoV‑2 Main Protease (Mpro) with Noncovalent Preclinical Candidate, Mpro61
title_short Exploring Possible Drug-Resistant Variants of SARS-CoV‑2 Main Protease (Mpro) with Noncovalent Preclinical Candidate, Mpro61
title_sort exploring possible drug resistant variants of sars cov 2 main protease mpro with noncovalent preclinical candidate mpro61
url https://doi.org/10.1021/acsbiomedchemau.4c00109
work_keys_str_mv AT jessicarkenneson exploringpossibledrugresistantvariantsofsarscov2mainproteasemprowithnoncovalentpreclinicalcandidatempro61
AT christinapapini exploringpossibledrugresistantvariantsofsarscov2mainproteasemprowithnoncovalentpreclinicalcandidatempro61
AT sutang exploringpossibledrugresistantvariantsofsarscov2mainproteasemprowithnoncovalentpreclinicalcandidatempro61
AT kathyhuynh exploringpossibledrugresistantvariantsofsarscov2mainproteasemprowithnoncovalentpreclinicalcandidatempro61
AT chunhuizhang exploringpossibledrugresistantvariantsofsarscov2mainproteasemprowithnoncovalentpreclinicalcandidatempro61
AT williamljorgensen exploringpossibledrugresistantvariantsofsarscov2mainproteasemprowithnoncovalentpreclinicalcandidatempro61
AT karensanderson exploringpossibledrugresistantvariantsofsarscov2mainproteasemprowithnoncovalentpreclinicalcandidatempro61